Discover 1,593 paid clinical trials in Washington State. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Washington State offers a wide range of paid volunteering opportunities for both healthy participants and those looking for condition-specific clinical studies. Key centers in Seattle, Spokane, and Tacoma are actively recruiting participants, providing access to advanced medical treatments and innovative care solutions.
Filter
1
Filter results
Results: 1,593
AIMS Cancer Outcomes Study
for
Neoplasms, Neoplasm Malignant, Advanced Cancer,
Location: Seattle WA
Sponsor: Advanced Integrative Medical Science Institute
Sex: All
Age: 0+
Code: NCT04495790
Recruiting
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
for
Bipolar Depression
Location: Richmond VA, West Palm Beach FL, Miami FL,
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 10 - 17
Code: NCT06372964
Phase3, Recruiting
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
for
Non-muscle Invasive Bladder Cancer
Location: Plymouth MA, Boston MA, The Bronx NY, New York NY,
Sponsor: Protara Therapeutics
Sex: All
Age: 18+
Code: NCT05951179
Phase2, Recruiting
BostonGene and Exigent Genomic INsight Study
for
Breast Cancer, Non-small Cell Lung Cancer, Melanoma, Sarcoma
Location: Fort Wayne IN, Rogers AR, Houston TX, Tulsa OK,
Sponsor: BostonGene
Sex: All
Age: 18+
Code: NCT06272864
Recruiting
Smart Ankle-Foot Orthosis to Improve Stroke Outcomes: Smart AFO
for
Stroke
Location: Troy MI, Edmonds WA
Sponsor: Orthocare Innovations, LLC
Sex: All
Age: 18+
Code: NCT05619484
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
TAP Blocks vs. IV Lidocaine for Kidney Transplants
for
Postoperative Pain
Location: Seattle WA
Sponsor: Benaroya Research Institute
Sex: All
Age: 18+
Code: NCT03843879
Phase2, Phase3, Recruiting
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis